Adp-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2): A new potential biomarker in huntington's disease

Journal of International Medical Research

Volumn 38, Issue 5, 2010, Pages 1653-1662

  Lovrecic, L ^a   Slavkov, I ^b   Dzeroski S ^b   Peterlin, B ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

ADP ribosylation factors; ARFGEF2; Biomarkers; Gene expression; Huntington's disease; Transcriptomics; Trinucleotide repeat diseases

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR 2; ALPHA ACTININ 4; BIOLOGICAL MARKER; DNA DIRECTED DNA POLYMERASE ALPHA; GOLGI AUTOANTIGEN GOLGIN SUBFAMILY A 8G; GUANINE NUCLEOTIDE EXCHANGE FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUNTINGTON CHOREA; MACHINE LEARNING; MALE; MICROARRAY ANALYSIS; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 78449311670     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800510     Document Type: Article

References (20)

1. Vonsattel JP, DiFiglia M: Huntington disease. J Neuropathol Exp Neurol 1998; 57: 369-384.
2. Imarisio S, Carmichael J, Korolchuk V: Huntington's disease: from pathology and genetics to potential therapies. Biochem J 2008; 412: 191-209.
3. The Huntington's Disease Collaborative Research Group: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
4. Harjes P, Wanker EE: The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci 2003; 28: 425-433.
5. Rachakonda V, Pan TH, Le WD: Biomarkers of neurodegenerative disorders: how good are they? Cell Res 2004; 14: 347-358.
6. Henley SM, Bates GP, Tabrizi SJ: Biomarkers for neurodegenerative diseases. Curr Opin Neurol 2005; 18: 698-705.
7. Huntington Study Group: Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996; 11: 136-142.
8. Shoulson I, Fahn S: Huntington disease: clinical care and evaluation. Neurology 1979; 29: 1-3.
9. Borovecki F, Lovrecic L, Zhou J, et al: Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci USA 2005; 102: 11023-11028.
10. Runne H, Kuhn A, Wild EJ, et al: Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci USA 2007; 104: 14424-14429.
11. Albanese D: BioDCV: a Distributed Computing System for the Complete Validation of Gene Profiles. Trento: University of Trento, 2005.
12. Vapnik V: Statistical Learning Theory (Adaptive and Learning Systems for Signal Processing, Communication and Control Series). New York: John Wiley, 1998.
13. Guyon I, Weston J, Barnhill S, et al: Gene selection for cancer classification using support vector machines. Mach Learn 2002; 46: 389-422.
14. Furlanello C, Serafini M, Merler S, et al: Entropy-based gene ranking without selection bias for the predictive classification of microarray data. BMC Bioinformatics 2003; 4: 54.
15. -ΔΔCT method. Methods 2001; 25: 402-408.
16. Rozen S, Skaletsky H: Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
17. Truant R, Atwal R, Burtnik A: Hypothesis: huntingtin may function in membrane association and vesicular trafficking. Biochem Cell Biol 2006; 84: 912-917.
18. Li XY, Li SH: HAP1 and intracellular trafficking. Trends Pharmacol Sci 2005; 26: 1-3.
19. Lee JK, Williams PD, Cheon S: Data mining in genomics. Clin Lab Med 2008; 28: 145-166.
20. Pirooznia M, Yang JY, Yang MQ, et al: A comparative study of different machine learning methods on microarray gene expression data. BMC Genomics 2008; 9(suppl 1): S13.